Companies / Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

Nasdaq: GLUECIK 1826457BOSTON, MA

Financials

Revenue—
Net income$-38.63M
Total debt—
Cash$90.10M
Diluted EPS—
Shares outstanding85.3M

Ownership

85.3M shares outstanding · as of Jul 31, 2026
1.0%Insiders
Ownership
Insiders1.05%892,923
Institutions85.48%72,927,418
Public float13.47%11,493,060

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Warmuth MarkusCEOPresident & CEO · Director
0.72%613,471
Townson SharonChief Scientific Officer
0.08%67,845
Janku FilipChief Medical Officer
0.08%65,837
Champoux JenniferChief Operating Officer
0.07%62,371
Nickson PhilipChief Business & Legal Officer
0.07%60,845
Dunn EdmundPrincipal Accounting Officer
0.03%22,554
Schiff Andrew NDirector
——

Institutional holders 174

View all →
HolderValue% of shares
BlackRock, Inc.$165.60M8.02%
NEA Management Company, LLC$120.62M9.02%
State Street Corporation$90.30M4.37%
Bvf INC/IL$73.38M5.23%
TCG Crossover Management, LLC$72.48M5.42%
Baker Bros. Advisors LP$71.49M5.09%
Versant Venture Management, LLC$68.72M5.14%
Suvretta Capital Management, LLC$52.68M3.94%
Vanguard Group Inc$50.91M3.81%
Geode Capital Management, LLC$25.35M1.81%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 27, 2026Dunn Edmund
Executive
SellCommon Stock$455.5K-25K
-52.58%
22,693
0.03% of shares
medium
Feb 27, 2026Dunn Edmund
Executive
ExerciseCommon Stock$337.4K+25K
+110.89%
47,857
0.06% of shares
low
Feb 23, 2026Janku Filip
Executive
SellCommon Stock$179.2K-9K
-12.25%
65,837
0.08% of shares
medium
Jan 5, 2026Warmuth Markus
CEO
SellCommon Stock$153.7K-10K
-1.60%
624,403
0.73% of shares
medium
Mar 2, 2026Warmuth Markus
CEO
SellCommon Stock$98.0K-5K
-0.88%
613,471
0.72% of shares
low
Jan 7, 2026Warmuth Markus
CEO
SellCommon Stock$86.2K-4K
-0.59%
620,696
0.73% of shares
low
Jan 5, 2026Nickson Philip
Executive
SellCommon Stock$47.9K-3K
-4.93%
60,845
0.07% of shares
low
Jan 5, 2026Janku Filip
Executive
SellCommon Stock$47.9K-3K
-4.04%
75,026
0.09% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Baker Bros. Advisors LPPassive13G/A———
Adam GoulburnPassive13G/A———
Biotechnology Value Fund L PPassive13G/A———
Baker Bros. Advisors LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
GLUE——61225M102—